Nancy J Hutson insider trades: Biocryst Pharmaceuticals (BCRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nancy reports to the SEC
Open-market buys and sales
29 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | BCRX | ↓ Sell10b5-1 | 7,000 | $7.54 | $53K | Direct | Dec 16, 2024 (3d) |
| May 20, 2024 | BCRX | ↑ Buy | 5,000 | $6.38 | $32K | Direct | May 22, 2024 (2d) |
| Oct 3, 2023 | CLSD | ↑ Buy | 10,000 | $0.86 | $9K | Direct | Oct 4, 2023 (1d) |
| Jun 14, 2023 | BCRX | ↓ Sell | 12,866 | $8.04 | $103K | Direct | Jun 15, 2023 (1d) |
| Nov 17, 2022 | CLSD | ↑ Buy | 30,000 | $1.33 | $40K | Direct | Nov 21, 2022 (4d) |
| Oct 15, 2021 | BCRX | ↓ Sell | 105,000 | $15.40 | $1.6M | Direct | Oct 19, 2021 (4d) |
| Aug 18, 2021 | PHAS | ↑ Buy | 3,000 | $3.08 | $9K | Held in an individual retirement account | Aug 19, 2021 (1d) |
| Aug 16, 2021 | CLSD | ↑ Buy | 3,000 | $5.68 | $17K | Direct | Aug 17, 2021 (1d) |
| Jun 10, 2021 | BCRX | ↓ Sell | 23,333 | $16.86 | $393K | Direct | Jun 14, 2021 (4d) |
| Mar 12, 2021 | CLSD | ↑ Buy | 5,000 | $3.10 | $16K | Direct | Mar 15, 2021 (3d) |
| May 20, 2020 | CLSD | ↑ Buy | 5,000 | $1.85 | $9K | Direct | May 21, 2020 (1d) |
| Nov 18, 2019 | BCRX | ↑ Buy | 10,000 | $1.45 | $15K | Direct | Nov 18, 2019 (0d) |
| Dec 17, 2018 | PHAS | ↑ Buy | 1,000 | $4.46 | $4K | Held in an individual retirement account | Dec 17, 2018 (0d) |
| Nov 15, 2018 | ENDP | ↓ Sell10b5-1 | 10,000 | $12.83 | $128K | Direct | Nov 16, 2018 (1d) |
| Mar 9, 2017 | ENDP | ↓ Sell10b5-1 | 5,325 | $10.82 | $58K | Direct | Mar 10, 2017 (1d) |
| Mar 1, 2016 | ENDP | ↓ Sell | 3,413 | $42.19 | $144K | Direct | Mar 3, 2016 (2d) |
| Feb 20, 2015 | BCRX | ↑ Buy | 10,000 | $10.27 | $103K | Direct | Feb 23, 2015 (3d) |
| Aug 18, 2014 | CBST | ↓ Sell | 9,000 | $65.00 | $585K | Direct | Aug 18, 2014 (0d) |
| Mar 10, 2014 | ENDP | ↓ Sell | 5,000 | $72.12 | $361K | Direct | Mar 11, 2014 (1d) |
| Jul 26, 2013 | CBST | ↓ Sell | 5,000 | $53.87 | $269K | Direct | Jul 29, 2013 (3d) |
| Apr 26, 2013 | CBST | ↓ Sell | 5,000 | $46.23 | $231K | Direct | Apr 26, 2013 (0d) |
| Jan 28, 2013 | CBST | ↓ Sell | 5,000 | $43.27 | $216K | Direct | Jan 30, 2013 (2d) |
| Oct 26, 2012 | CBST | ↓ Sell | 5,000 | $43.52 | $218K | Direct | Oct 30, 2012 (4d) |
| Oct 26, 2011 | CBST | ↑ Buy | 1,500 | $38.66 | $58K | Direct | Oct 28, 2011 (2d) |
| Dec 7, 2010 | ENDP | ↑ Buy | 1,000 | $36.38 | $36K | By IRA | Dec 9, 2010 (2d) |
| Nov 9, 2010 | ISPH | ↑ Buy | 7,000 | $6.99 | $49K | Direct | Nov 12, 2010 (3d) |
| May 13, 2009 | ENDP | ↑ Buy | 3,000 | $16.31 | $49K | Direct | May 18, 2009 (5d) |
| Oct 23, 2008 | CBST | ↑ Buy | 2,000 | $21.03 | $42K | Direct | Oct 27, 2008 (4d) |
| Mar 12, 2007 | ISPH | ↑ Buy | 7,800 | $6.35 | $50K | Direct | Mar 13, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BCRX insiders
Open-market trades in the last 12 months
About Nancy J Hutson's insider trades
Nancy J Hutson is a director at Biocryst Pharmaceuticals (BCRX). Since Mar 12, 2007, Nancy has reported 16 open-market purchases worth $537K and 13 sales worth $4.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
3 sales (5% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (71 filings), option exercises (17 filings), shares withheld for taxes (5 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BCRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.